JULIE MARTIN: Open Payments
NPI 1952534596 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$906 in 32 payments from 13 companies in 2025. Trend: 2023 $918 · 2024 $863 · 2025 $906
Food & beverage: $906
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 10 | $335 |
| Astellas Pharma US Inc | 5 | $126 |
| Lilly USA, LLC | 1 | $120 |
| AstraZeneca Pharmaceuticals LP | 4 | $74 |
| Daiichi Sankyo Inc. | 2 | $58 |
| ABBVIE INC. | 3 | $53 |
| Boston Scientific Corporation | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Antares Pharma, Inc. | 1 | $23 |
| Seqirus USA Inc | 1 | $20 |
Products named: FREESTYLE LIBRE 3, Veozah, ZEPBOUND, BREZTRI, INJECTAFER, WATCHMAN FLX, REXULTI, XYOSTED.
Industry payments across LA — which companies pay providers there.
